š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The goal of this clinical trial is to determine whether cannabidiol (CBD, 2...
Status
Recruiting
Location
Shaare Zedek Medical Center
Start Date
2025-10-05
Trial ID
NCT07199218
Treatments Being Tested
This is a pilot clinical trial of dronabinol to treat disabling attacks of ...
Status
Withdrawn
Location
NYU Medical Center
Start Date
2015-11
Trial ID
NCT02608931
Treatments Being Tested
The study examines the effects of delta-9-tetrahydrocannabinol (Ī9-THC), th...
Status
Completed
Location
VA Connecticut Healthcare System
Start Date
2008-02-25
Trial ID
NCT00708994
Persistent postsurgical abdominal pain (PPAP) is a very difficult to treat ...
Status
Completed
Location
Radboud University Nijmegen Medical Centre
Start Date
2012-10
Trial ID
NCT01562483
Treatments Being Tested
This is a multi-centre, long term, double blind, clinical protocol for Nana...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11
Trial ID
NCT04808531
Treatments Being Tested
The overarching goal of this study is to characterize the effects of ethano...
Status
Active Not Recruiting
Location
Biological Studies Unit, VA Connecticut Healthcare System
Start Date
2016-03
Trial ID
NCT02709954
Treatments Being Tested
The main goal of this trial is to study the efficacy of NamisolĀ® after a si...
Status
Completed
Location
Radboud University Nijmegen Medical Centre
Start Date
2011-10
Trial ID
NCT01318369
This clinical trial is being done to better understand how daily treatment ...
Status
Recruiting
Location
University of Michigan
Start Date
2022-02-22
Trial ID
NCT04992624
Glaucoma is among the leading causes for irreversible blindness worldwide. ...
Status
Completed
Location
Department of Clinical Pharmacology, Medical University Vienna
Start Date
2020-11-11
Trial ID
NCT04596826
Treatments Being Tested